DaVita
DVA
#2201
Rank
A$12.54 B
Marketcap
A$175.45
Share price
-0.32%
Change (1 day)
-28.54%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): A$15.54

According to DaVita's latest financial reports the company's current EPS (TTM) is A$14.95. In 2024 the company made an earnings per share (EPS) of A$16.59 an increase over its 2023 EPS that were of A$11.44.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$15.54-6.3%
2024A$16.5944.94%
2023A$11.4427.26%
2022A$8.99-35.56%
2021A$13.9644.1%
2020A$9.6819.7%
2019A$8.09540.48%
2018A$1.26-76.07%
2017A$5.28-19.31%
2016A$6.54242.52%
2015A$1.91-62.87%
2014A$5.1413.43%
2013A$4.538.45%
2012A$4.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
A$22.11 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.86-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
A$32.11 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$15.41 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA